Storage and handling
Store at 68-77 O F (20-25 O C) For intrarectal application use Avenoc Suppositories.
Store at 68-77 O F (20-25 O C) For intrarectal application use Avenoc Suppositories.
Aesculus hippocastanum 1X, Collinsonia canadensis 1X, Hamamelis virginiana 1X
Temporary relieves minor symptoms of hemorrhoids such as soreness, itching, burning.
Do not use if glued carton end flaps are open or if the tube seal is broken.
Adults and children 12 years of age and older: When practical, gently cleanse the
affected area with mild soap and warm water and rinse thoroughly. Do not dry.
Apply externally to the affected area up to 4 times a day.
Children under 12 years of age: Ask a doctor.
White petrolatum USP-NF
Tube 1 OZ (30 G)
Aesculus hippocastanum 1X HPUS - 1.3%... Relieves stinging pain associated with external hemorrhoids
Collinsonia canadensis 1X HPUS - 1.3%... Relieves painful hemorrhoids associated with constipation
Hamamelis virginiana 1X HPUS - 1.3% ... Relieves hemorrhoids with a tendency to bleed
Store at 68-77
O F (20-25
O C)
For intrarectal application use Avenoc Suppositories.
Questions, Comments?
info@boironusa.com
1-800-BOIRON-1 (1-800-264-7661)
Distributed by Boiron Inc.
6 Campus Boulevard
Newtown Square, PA 19073-3267
Ask a doctor before use in case of bleeding.
Stop use and ask doctor if symptoms persist for more than 7 days or worsens.
Keep out of reach of children
If pregnant or breast-feeding, ask a health professional before use.
Safe - Soothing - Paraben-Free - Works naturally with your body
For external use only. Do not put this product into the rectum by using fingers or any other mechanical device or applicator.
When using this product, do not exceed the recommended daily dosage unless directed by a doctor.
If swallowed, get medical help or contact a Poison Control Center right away.
Avenoc Ointment Image
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0220-9013-51 | 2023-11-29 | C162847 | 48780-1 | f386c64a-0b89-0266-e053-dadaa90a7c1a | AVENOC OINTMENT |
| 0220-9013-51 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0b89-0266-e053-dadaa90a7c1a | AVENOC OINTMENT |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| COLLINSONIA CANADENSIS ROOT | ACTIVE INGREDIENT | O2630F3XDR | 2 | |
| HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK | ACTIVE INGREDIENT | T7S323PKJS | 2 | |
| HORSE CHESTNUT | ACTIVE INGREDIENT | 3C18L6RJAZ | 2 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE MOIETY | O2630F3XDR | 2 | |
| HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK | ACTIVE MOIETY | T7S323PKJS | 2 | |
| HORSE CHESTNUT | ACTIVE MOIETY | 3C18L6RJAZ | 2 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0220-9013 | 0220-9013-51 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PETROLATUM | 4T6H12BN9U | IACT |
| HORSE CHESTNUT | 3C18L6RJAZ | ACTIB |
| COLLINSONIA CANADENSIS ROOT | O2630F3XDR | ACTIB |
| HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK | T7S323PKJS | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0b508c1c-542f-5a82-e063-6294a90ab8c6 | c9df6176-5ff6-4894-a085-c0ccf32e39f7 | 2023-11-29 | Warnings | 0b508c1c-542f-5a82-e063-6294a90ab8c6 c9df6176-5ff6-4894-a085-c0ccf32e39f7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.